D'Andrea G., Pizzolato G., Gucciardi A., Stocchero M., Giordano G., Baraldi E., Leon A. Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson's Disease Patients. Sci Rep. 2019 Apr 16;9(1):6151.

D'Andrea G., Gucciardi A., Perini F., Leon A. The role of neurotransmitters and neuromodulators in the pathogenesis of cluster headache: a review. Neurol Sci. 2019 May;40(Suppl 1):39-44.

Marzollo A., Colavito D., Sartori S., Fanelli GN., Putti MC. Cerebral Lymphoproliferation in a Patient with Kabuki Syndrome. J Clin Immunol. 2018 May;38(4):475-477.

Cananzi M., Colavito D., Giorgi B. A Case of Constipation That Passed From Father to Son. Gastroenterology. 2018 Nov;155(5):1317-1318.


Colavito D., Del Giudice E., Ceccato C., Dalle Carbonare M., Leon A., Suppiej A. Are CSNK2A1 gene mutations associated with retinal dystrophy? Report of a patient carrier of a novel de novo splice site mutation. J Hum Genet. 2018 Jun;63(6):779-781.


Colavito D., Maritan V., Suppiej A., Del Giudice E., Mazzarolo M., Miotto S., Farina S., Dalle Carbonare M., Piermarocchi S., Leon A. Non-syndromic isolated dominant optic atrophy caused by the p.R468C mutation in the AFG3 like matrix AAA peptidase subunit 2 gene. Biomed Rep. 2017 Nov;7(5):451-454.

Piermarocchi S., Miotto S., Colavito D., Del Giudice E., Leon A., Maritan V., Piermarocchi R., Tormene AP. Long-term rearrangement of retinal structures in a novel mutation of X-linked retinoschisis. Biomed Rep. 2017 Sep;7(3):241-246.


D'Andrea G., Bussone G., Di Fiore P., Perini F., Gucciardi A., Bolner A., Aguggia M., Saracco G., Galloni E., Giordano G., Leon A. Pathogenesis of chronic cluster headache and bouts: role of tryptamine, arginine metabolism and α(1)-agonists. Neurol Sci. 2017 May;38(Suppl 1):37-43.


Piermarocchi S., Segato T., Leon A., Colavito D., Miotto S. Occult macular dystrophy in an Italian family carrying a mutation in the RP1L1 gene. Mol Med Rep. 2016 Mar;13(3):2308-12.


Piermarocchi S., Miotto S., Colavito D., Leon A., Segato T. Combined effects of genetic and non-genetic risk factors affect response to ranibizumab in exudative age-related macular degeneration. Acta Ophthalmol. 2015 Sep;93(6):e451-7.